A Preliminary study on the preoperative risk score system for simultaneous operation for patients with colorectal cancer and liver metastases
10.3760/cma.j.cn113884-20200421-00211
- VernacularTitle:同时性结直肠癌肝转移患者同期手术的术前危险度评分体系初探
- Author:
Jinke SUI
1
;
Nanxin ZHENG
;
Fuao CAO
;
Guanyu YU
;
Xiaoming ZHU
;
Haifeng GONG
;
Zheng LOU
;
Liqiang HAO
;
Ronggui MENG
;
Wei ZHANG
Author Information
1. 上海长海医院肛肠外科 200433
- From:
Chinese Journal of Hepatobiliary Surgery
2020;26(7):522-525
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This study aims to analyze the prognosis of patients who underwent a simultaneous operations for colorectal cancer and liver metastases, and to establish a prognostic scoring system for these patients.Methods:From January 2010 to March 2019, the clinicopathological data of patients with colorectal cancer and liver metastases simultaneously operated at Shanghai Changhai Hospital were collected. The clinicopathological prognostic factors on tumor recurrence and survival outcomes on follow-up were analyzed. Single and multiple factors Cox regression analyses were used to determine the risk factors which affected the prognosis of patients. Using the risk factors of poor prognosis on Cox analysis, 1 point was given to each risk factor. Patients were then divided into different groups according to the different total scores. The median overall survival and disease-free survival of each group were analyzed.Results:Of 234 patients included in this study, there were 126 males and 108 females. The average age was (57.4±10.8) years. The median survival was 44.85 months. The 1-, 3-, and 5-year survival rates of the whole group were 87.3%, 55.2%, and 22.9%, respectively. Primary tumor in right colon, preoperative carcinoembryonic antigen ≥200 ng/ml, multiple liver metastases, and poorly differentiated adenocarcinoma/mucinous adenocarcinoma were independent risk factors of poor prognosis. After 1 point was given to each of the above 4 items, patients were then divided into the low-risk (0-1) and high-risk (2-4) groups. The median survivals of patients in the low-risk group ( n=174) and high-risk group ( n=60) were 53 months and 29 months, respectively. The corresponding median disease-free survivals were 21.34 months and 8.48 months, respectively. The differences between the 2 groups were significant ( P<0.05). Conclusion:The results of this study preliminary established a predictive scoring system for patients with simultaneous colorectal cancer and liver which can play a role in selecting treatment options for these patients.
